Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 11 Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) 1 NSCLC 1 Melanoma 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Cisplatin 11 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 pembrolizumab 6 durvalumab 6 Platinum 6 1,2-diaminocyclohexaneplatinum II citrate 6 cemiplimab 5 Carboplatin 5 Radiation 4 Cetuximab 4 Biopsy 4 poly ICLC 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Pemetrexed 3 Paclitaxel 3 Nivolumab 3 Docetaxel 3 (225)Ac-DOTA-c(RGDyK) 3 ipatasertib 2 cabozantinib 2 atezolizumab 2 Oxaliplatin 2 Ipilimumab 2 Immunoglobulin G 2 Fluorouracil 2 Disulfides 2 Capecitabine 2 ALT-803 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × osimertinib × 30 days × Clear all

NCT06417814 2026-05-14

TROPION-Lung15

AstraZeneca

Phase 3 Recruiting

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡